WuXi Chemistry, a business division of WuXi AppTec, provides contract services for new drug development from discovery to commercial. Our unique CRDMO model offers an integrated solution combining traditional CRO (contract research organization), CDMO (contract development and manufacturing organization) and CMO (contract manufacturing organization) services under one roof.
As a world leading chemistry service organization, WuXi Chemistry have over 24,137 employees from our 16 research, development or manufacturing sites worldwide, serving over 2,014 clients from top pharma to virtual biotech companies. Our services cover all categories for all synthetic molecular modalities, meeting any material requirement at any scale.
Target to Hit
Hit to Lead
Lead to PCC
Dr. Tao Guo Addressed a Keynote Speech at the "Medicinal Chemistry Strategy Meeting East Coast USA 2022"
WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility in Middletown, Delaware